Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aron Chakera

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Biochemistry|October 15, 2009
The platelet receptor CLEC-2 is active as a dimerAleksandra A Watson, Charita M Christou, John R James, et al.
BMC Health Services Research|November 26, 2024
Estimating the cost of chronic kidney disease in AustraliaSean Randall, Crystal M Y Lee, Elizabeth Thomas, et al.
Nephrology (Carlton, Vic.)|February 11, 2026
Five-Year Outcomes of Chronic Kidney Disease in a Longitudinal Population-Based Cohort in Western AustraliaElizabeth Thomas, Kevin E K Chai, Crystal M Y Lee, et al.
BMC Nephrology|April 17, 2026
Geographic remoteness and chronic kidney disease outcomes: a population-based cohort study using linked pathology dataJasmine K H Sidhu, Elizabeth Thomas, Sharmani Barnard, et al.
Clinical & Experimental Ophthalmology|May 2, 2021
Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1-3 tyrosine kinase inhibitor anticancer therapyJason Charng, Mary S Attia, Sukanya Arunachalam, et al.
Lung Cancer (Amsterdam, Netherlands)|January 6, 2020
A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesotheliomaWei-Sen Lam, Jenette Creaney, Fred K Chen, et al.
BMJ Open|August 7, 2019
Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocolKushani Jayasinghe, Zornitza Stark, Chirag Patel, et al.
HLA|December 5, 2024
Clinical Applicability of 2-Field High-Resolution and Extended HLA-Allele Typing in Deceased Donor Kidney AllocationZhan Lim, Anne Taverniti, Jonathan Downing, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 20, 2026
Evaluation of common urine leukocyte dipsticks for diagnosing peritoneal dialysis (PD)-associated peritonitisRasha Hussein, Nadja Grobe, Nahla Allam, et al.
Transplantation|June 17, 2020
The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020Jonathan Bromberg, Carla Baan, Jeremy Chapman, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Biochemistry|October 15, 2009
The platelet receptor CLEC-2 is active as a dimerAleksandra A Watson, Charita M Christou, John R James, et al.
BMC Health Services Research|November 26, 2024
Estimating the cost of chronic kidney disease in AustraliaSean Randall, Crystal M Y Lee, Elizabeth Thomas, et al.
Nephrology (Carlton, Vic.)|February 11, 2026
Five-Year Outcomes of Chronic Kidney Disease in a Longitudinal Population-Based Cohort in Western AustraliaElizabeth Thomas, Kevin E K Chai, Crystal M Y Lee, et al.
BMC Nephrology|April 17, 2026
Geographic remoteness and chronic kidney disease outcomes: a population-based cohort study using linked pathology dataJasmine K H Sidhu, Elizabeth Thomas, Sharmani Barnard, et al.
Clinical & Experimental Ophthalmology|May 2, 2021
Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1-3 tyrosine kinase inhibitor anticancer therapyJason Charng, Mary S Attia, Sukanya Arunachalam, et al.
Lung Cancer (Amsterdam, Netherlands)|January 6, 2020
A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesotheliomaWei-Sen Lam, Jenette Creaney, Fred K Chen, et al.
BMJ Open|August 7, 2019
Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocolKushani Jayasinghe, Zornitza Stark, Chirag Patel, et al.
HLA|December 5, 2024
Clinical Applicability of 2-Field High-Resolution and Extended HLA-Allele Typing in Deceased Donor Kidney AllocationZhan Lim, Anne Taverniti, Jonathan Downing, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 20, 2026
Evaluation of common urine leukocyte dipsticks for diagnosing peritoneal dialysis (PD)-associated peritonitisRasha Hussein, Nadja Grobe, Nahla Allam, et al.
Transplantation|June 17, 2020
The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020Jonathan Bromberg, Carla Baan, Jeremy Chapman, et al.
Pageof 9